Mithra signs deal with Orifarm

Mithra Pharmaceuticals has signed an exclusive license and supply agreement with Danish firm Orifarm to sell Myring (ethinylestradiol/etonogestrel), the Belgian women’s health specialist’s generic version of Merck & Co’s NuvaRing, in Denmark.